Evidence map›Paper›PMID 38542807›Full record

Trial reportNutrients2024

The Effect of Prior Creatine Intake for 28 Days on Accelerated Recovery from Exercise-Induced Muscle Damage: A Double-Blind, Randomized, Placebo-Controlled Trial.

Shota Yamaguchi, Takayuki Inami, Hiroyuki Ishida, Akihisa Morito, Satoshi Yamada, Naoya Nagata, Mitsuyoshi Murayama

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shota YamaguchiInstitute of Physical Education, Keio University, Yokohama 223-8521, Japan.ORCID 0000-0002-6655-9881
Takayuki InamiInstitute of Physical Education, Keio University, Yokohama 223-8521, Japan.ORCID 0000-0002-7299-170X
Hiroyuki IshidaSports Medicine Research Center, Keio University, Yokohama 223-8521, Japan.
Akihisa MoritoTaisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.ORCID 0000-0002-8515-1064
Satoshi YamadaTaisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.ORCID 0000-0003-1892-5696
Naoya NagataInstitute of Physical Education, Keio University, Yokohama 223-8521, Japan.
Mitsuyoshi MurayamaInstitute of Physical Education, Keio University, Yokohama 223-8521, Japan.
Keio University · JPTaisho Pharmaceutical (Japan) · JP

Funding

Taisho Pharmaceutical (Japan) H11PA22111
6 · The paper itself

Abstract

Despite the known beneficial effects of creatine in treating exercise-induced muscle damage (EIMD), its effectiveness remains unclear. This study investigates the recovery effect of creatine monohydrate (CrM) on EIMD. Twenty healthy men (21-36 years) were subjected to stratified, randomized, double-blind assignments. The creatine (CRE) and placebo (PLA) groups ingested creatine and crystalline cellulose, respectively, for 28 days. They subsequently performed dumbbell exercises while emphasizing eccentric contraction of the elbow flexors. The EIMD was evaluated before and after exercise. The range of motion was significantly higher in the CRE group than in the PLA group 24 h (h) post exercise. A similar difference was detected in maximum voluntary contraction at 0, 48, 96, and 168 h post exercise (

Indexed as

CreatineMyalgiaDietary SupplementsHumansMaleMuscle, SkeletalPolyestersPost-Exercise RecoveryCreatinePolyesterscreatine monohydratedietary supplementationeccentric exerciseexercise-induced muscle damage

Identifiers

PMID38542807
PMCPMC10975653
OpenAlexW4393005057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.